company

PHARMA HELSE AS

1543 VESTBY

Return on Equity
71,1 %
Current Ratio
0,54
Debt-to-Equity Ratio
−0,54
Key figures (NOK)2022
Revenue1 488 000
Net Income−438 000
Total Assets369 000
Total Equity−616 000
Income (NOK)2022
Revenue1 488 000
Expenditure1 921 000
Operating Profit−434 000
Financial Income−5 000
Financial Costs0
Financial Balance−5 000
Earnings Before Tax−438 000
Tax0
Net Income−438 000
Balance (NOK)2022
Total Fixed Assets16 000
Total Current Assets353 000
Total Assets369 000
Total Retained Equity−716 000
Total Equity−616 000
Total Long-Term Debt335 000
Total Current Debt650 000
Total Equity and Debt369 000
Cash flow (NOK)2022
Sales Income1 488 000
Other Income0
Revenue1 488 000
Cost of Goods Sold1 471 000
Salary Costs0
Depreciation0
Impairment0
Expenditure1 921 000
Operating Profit−434 000
Financial Income−5 000
Financial Costs0
Financial Balance−5 000
Dividends0
Net Income−438 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets16 000
Total Fixed Assets16 000
Stock179 000
Total Investments0
Cash, Bank23 000
Total Current Assets353 000
Total Assets369 000
Total Equity−616 000
Short-Term Group Debt0
Total Long-Term Debt335 000
Creditors322 000
Unpaid Taxes0
Dividends0
Other Current Debt328 000
Total Current Debt650 000
Total Equity and Debt369 000
Financial indicators2022
Return on Equity71,1 %
Debt-to-Equity Ratio−0,54
Operating Profit Margin−29,17 %
Current Ratio0,54
Quick Ratio0,75
Equity Ratio−1,67
Gross Profit Margin1,14 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English